GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (FRA:CVG) » Definitions » Inventories, Work In Process

CSPC Pharmaceutical Group (FRA:CVG) Inventories, Work In Process : €32 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group Inventories, Work In Process?

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. CSPC Pharmaceutical Group's work in process for the quarter that ended in Dec. 2023 was €32 Mil.


CSPC Pharmaceutical Group Inventories, Work In Process Historical Data

The historical data trend for CSPC Pharmaceutical Group's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Inventories, Work In Process Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.55 25.63 41.03 38.49 32.36

CSPC Pharmaceutical Group Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.49 - - - 32.36

CSPC Pharmaceutical Group Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.


CSPC Pharmaceutical Group (FRA:CVG) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (FRA:CVG) Headlines

From GuruFocus

WeissLaw LLP Investigates Convergys Corporation

By PRNewswire PRNewswire 06-30-2018

Convergys Corp. Reports Operating Results (10-K)

By gurufocus 10qk 02-25-2011

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-08-2010

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 05-05-2010

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2009

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-09-2010

A cheap dutch stock - Crown van Gelder

By batbeer2 batbeer2 01-09-2011